From our experience as a Contract Research Organization (CRO) working across multiple therapeutic areas and regions, here are the key lessons business owners must understand before investing in Biosimilar Clinical Trials. Why Are Biosimilar Clinical Trials Necessary When the Reference…
As the patents for blockbuster biologics expire, a new era of opportunity emerges, ushering in the rise of biosimilars. These biologic alternatives offer the promise of affordable care, broader global access, and lucrative growth for pharmaceutical companies. But the key…
The rising prevalence and large market share of biological products emphasize their importance as treatment options for several cancers and autoimmune diseases. In contrast to chemically synthesized molecules, biologicals are large and complex due to their natural origin with complicated…
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.